
General articles are free for 24 hours after publish.
Indonesia Actively Develops Vaccines to Accelerate TB Elimination
Indonesia is prioritizing domestic vaccine development to accelerate the elimination of tuberculosis (TB), aligning with World Health Organization (WHO) goals. Research institutions and pharmaceutical companies are collaborating to establish new prevention and treatment methods.
Indonesia is actively promoting domestic vaccine development to accelerate its efforts toward the elimination of tuberculosis (TB). The nation aims to achieve the World Health Organization's (WHO) goal of TB elimination by 2030, with domestic research institutions and pharmaceutical companies collaborating to establish new prevention and treatment methods. Indonesia is one of the countries with a high incidence of TB, making it a significant public health challenge. In addition to existing treatments, the development of more effective and accessible vaccines is considered essential for controlling the spread of infection and reducing the burden on patients. The government plans to expedite vaccine development by expanding investment in research and development and exploring international cooperation. Through these efforts, Indonesia aims to reduce the number of TB-related deaths and the incidence rate. Source: Antara News (English)
Original source
Antara News (English)